Are You Eligible for a New Therapy That Might Prevent COVID-19? Learn More On Evusheld
For You
News & Perspective
Drugs & Diseases
CME & Education
Academy
Video
Decision Point

Specialty: Multispecialty
Allergy & Immunology
Anesthesiology
Business of Medicine
Cardiology
Critical Care
Dermatology
Diabetes & Endocrinology
Emergency Medicine
Family Medicine
Gastroenterology
General Surgery
Hematology - Oncology
HIV/AIDS
Hospital Medicine
Infectious Diseases
Internal Medicine
Multispecialty
Nephrology
Neurology
Ob/Gyn & Women's Health
Oncology
Ophthalmology
Orthopedics
Pathology & Lab Medicine
Pediatrics
Plastic Surgery
Psychiatry
Public Health
Pulmonary Medicine
Radiology
Rheumatology
Transplantation
Urology
Medical Students
Nurses
Pharmacists
Residents
Today on Medscape
Edition: English

Medscape

English
Deutsch
Español
Français
Português
UKNew

Univadis

Français New
Italiano New
Sign Up It's Free!
English Edition

Medscape

Univadis

X
Univadis from Medscape

No Results

    Tuesday, May 24, 2022
    For You News & Perspective Drugs & Diseases CME & Education Academy Video Decision Point
    Perspective > WebMD > Coronavirus in Context

    Are You Eligible for a New Therapy That Might Prevent COVID-19? Learn More On Evusheld

    John Whyte, MD

    Disclosures

    May 09, 2022

    5

    Download Slides
    Are You Eligible for a New Therapy That Might Prevent COVID-19? Learn More On Evusheld
    Are You Eligible for a New Therapy That Might Prevent COVID-19? Learn More On Evusheld
    00:00
    00:0002:14GO LIVE

    Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center.

    WebMD's Chief Medical Officer, John Whyte, MD, discusses the new FDA-authorized preventative drug for COVID-19 called Evusheld.

    This interview originally appeared on WebMD on May 9, 2022

    Follow Medscape on Facebook, Twitter, Instagram, and YouTube

    Recommendations

    Comments

    3090D553-9492-4563-8681-AD288FA52ACE
    Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.

    processing....

    Feedback
    Help us make reference on Medscape the best clinical resource possible. Please use this form to submit your questions or comments on how to make this article more useful to clinicians.
    Pleasedo not use this form to submit personal or patient medical information or to report adverse drug events. You are encouraged to report adverse drug event information to the FDA.
    Find Us On
    About
    About Medscape Privacy Policy Editorial Policy Cookies Terms of Use Advertising Policy Help Center
    Membership
    Become a Member About You Professional Information Newsletters & Alerts
    App
    Medscape
    WebMD Network
    Medscape Live Events WebMD MedicineNet eMedicineHealth RxList WebMD Corporate
    Editions
    English Deutsch Español Français Português
    All material on this website is protected by copyright, Copyright © 1994-2022 by WebMD LLC. This website also contains material copyrighted by 3rd parties.